Y. Piquet

540 total citations
22 papers, 371 citations indexed

About

Y. Piquet is a scholar working on Hepatology, Hematology and Infectious Diseases. According to data from OpenAlex, Y. Piquet has authored 22 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 7 papers in Hematology and 4 papers in Infectious Diseases. Recurrent topics in Y. Piquet's work include Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (4 papers) and Blood groups and transfusion (4 papers). Y. Piquet is often cited by papers focused on Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (4 papers) and Blood groups and transfusion (4 papers). Y. Piquet collaborates with scholars based in France, Slovakia and United States. Y. Piquet's co-authors include Pierre Gallian, Pierre Tiberghien, Jacques Izopet, Karine Sauné, Sébastien Lhomme, Florence Abravanel, Azzedine Assal, Syria Laperche, G Vezon and Françoise Bouchardeau and has published in prestigious journals such as Nature Biotechnology, Emerging infectious diseases and Journal of Medical Virology.

In The Last Decade

Y. Piquet

21 papers receiving 351 citations

Peers

Countries citing papers authored by Y. Piquet

Since Specialization

Citations

This map shows the geographic impact of Y. Piquet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Piquet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Piquet more than expected).

Fields of papers citing papers by Y. Piquet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Piquet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Piquet. The network helps show where Y. Piquet may publish in the future.

Co-authorship network of co-authors of Y. Piquet

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Piquet. A scholar is included among the top collaborators of Y. Piquet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Piquet. Y. Piquet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Estimation d’un risque transfusionnel émergent : l’exemple du VHE 2014 ·Transfusion Clinique et Biologique ·Josiane Pillonel, Pierre Gallian, Cécile Sommen, Élisabeth Couturier, Y. Piquet, Rachid Djoudi, Syria Laperche	8
2	Virus de l’hépatite E, implications en transfusion sanguine 2014 ·Transfusion Clinique et Biologique ·Pierre Gallian, Y. Piquet, A. Assal, Rachid Djoudi, Jacques Chiaroni, Jacques Izopet, Pierre Tiberghien	16
3	Hepatitis E Virus Infections in Blood Donors, France 2014 ·Emerging infectious diseases ·Pierre Gallian, Sébastien Lhomme, Y. Piquet, Karine Sauné, Florence Abravanel, Azzedine Assal, Pierre Tiberghien, Jacques Izopet	101
4	Validation d’un test de dépistage de l’ARN du VHE dans le cadre de la prévention de la transmission par le PFC-SD 2013 ·Transfusion Clinique et Biologique ·Y. Piquet, (unknown), (unknown), (unknown), (unknown), (unknown), Pierre Gallian, A. Assal, (unknown)	1
5	Two cases of transfusion‐transmitted hepatitis B virus (HBV) infection in a low‐endemic country before implementation of HBV nucleic acid testing 2012 ·Transfusion ·Annabelle Servant‐Delmas, (unknown), (unknown), Y. Piquet, (unknown), (unknown), (unknown), Sébastien Hantz, Sophie Alain, Syria Laperche	7
6	Détection du génome viral du parvovirus B19 dans les pools de plasmas servant à la préparation du plasma frais congelé traité pour viro-atténuation par solvant–détergent : expérience de l’Afssaps et de l’EFS Aquitaine-Limousin 2010 ·Transfusion Clinique et Biologique ·Rachel Petermann, Y. Piquet, (unknown), (unknown), Marie Gauthier, (unknown), (unknown), (unknown), J.-M. Boiron	1
7	A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases 2008 ·Transfusion ·Syria Laperche, M. Maniez, Valérie Barlet, (unknown), Françoise Le Vacon, (unknown), F. Lunel, Pascal Morel, (unknown), Y. Piquet, Josiane Pillonel	12
8	Molecular characterization of genotype 2 and 4 hepatitis C virus isolates in French blood donors 2008 ·Journal of Medical Virology ·Jean‐François Cantaloube, Pierre Gallian, Syria Laperche, (unknown), Y. Piquet, Françoise Bouchardeau, François Jordier, Philippe Biagini, Houssam Attoui, Philippe de Micco	24
9	Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing? 2005 ·Transfusion ·Syria Laperche, (unknown), Pascal Morel, Marianne Asso‐Bonnet, Nadine Le Marrec, A Girault, Annabelle Servant‐Delmas, Françoise Bouchardeau, Marie Deschaseaux, Y. Piquet	45
10	[Plasma exchanges and replacement fluids for adult thrombotic microangiopathy. Synopsis of the Round table held on May 3, 2001]. 2002 ·PubMed ·(unknown), (unknown), Paul Coppo, Jean-Michel Korach, (unknown), A Bussel, Françoise Driss, Bertrand Guidet, Y. Piquet, Jacques Pourrat, (unknown), Agnès Veyradier, Dominique Vignon	3
11	Tests de dépistage combiné des anticorps anti-VIH et de l'antigène p24 1999 ·Anne Couroucé, Françis Barin, S. Chamaret, Fabienne Durand, M.H. Elghouzzi, Syria Laperche, J.M. Lemaire, Patrick Maisonneuve, M. Maniez, P. Moncharmont, Pascal Morel, Fabrice Morin, (unknown), Lina Noël, (unknown), Josiane Pillonel, Y. Piquet, C. Rouzioux, C. Saura, (unknown)	12
12	Atténuation virale des produits sanguins labiles 1996 ·Transfusion Clinique et Biologique ·Gilles Folléa, Pierre‐Louis Hervé, G. Andreu, (unknown), (unknown), (unknown), L. Noël, Y. Piquet	1
13	Virus Inactivation of Fresh Frozen Plasma by a Solvent Detergent Procedure: Biological Results 1992 ·Vox Sanguinis ·Y. Piquet, G Janvier, (unknown), C. Doutremepuich, (unknown), (unknown), Denis Platel, G Vezon	38
14	Choosing a Host Cell for Active Recombinant Factor VIII Production Using Vaccinia Virus 1987 ·Nature Biotechnology ·Andréa Pavirani, Pierre Meulien, (unknown), (unknown), Karin Dott, Dominique Villeval, (unknown), (unknown), Claudine Mazurier, (unknown), Y. Piquet, Jean‐Pierre Cazenave, Jean‐Pierre Lecocq	16
15	Characterization of a murine monoclonal antibody specific for the human P1 blood group antigen 1987 ·Molecular Immunology ·Pascal Bailly, J. Chevaleyre, (unknown), (unknown), Y. Piquet, (unknown), Jean‐Pierre Cartron	6
16	Platelet Kinetics in Stable Atopic Asthmatic Patients ^1, ² 1986 ·American Review of Respiratory Disease ·A Taytard, H. Guénard, (unknown), (unknown), J Vergeret, D. Ducassou, Y. Piquet, P Fréour	44
17	Soluble fibrinogen derivatives generated by thrombin:Affinity for elastik 1986 ·Thrombosis Research ·M. Rabaud, F. Lefèbvre, Y. Piquet, Françis Belloc, (unknown), (unknown), H Bricaud	14
18	Technical Aspects of Different Donor Plasmapheresis Systems and Biological Results Obtained in Collected Plasma 1986 ·Vox Sanguinis ·G Vezon, Y. Piquet, (unknown), F Schooneman, (unknown), (unknown)	16
19	Identification of a factor blocking a cellular cytotoxicity reaction in pregnant serum. 1983 ·PubMed ·(unknown), Jean Bousquet, Y. Piquet, (unknown)	4
20	[Excretion in rat urine of substances derived from the basal glomerular membrane]. 1977 ·PubMed ·J. Cambar, Y. Piquet, (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact